Health In Tech Inc-A美股招股说明书(2026-06-24版)

Health In Tech, Inc.5,600,000 Shares ofClass A Common StockOffered by the Selling Stockholders This prospectus relates to the proposed resale or other disposition of up to 5,600,000 shares of Class A common stock, $0.001par value per share (“Class A Common Stock”), of Health In Tech, Inc. by the selling stockholders identified in this prospectus fromtime to time in one or more offerings. This prospectus provides you with a general description of the securities. We will not receiveany proceeds from the sale of our Class A Common Stock by the selling stockholders. The selling stockholders or their permitted pledgees, assignees or successors-in-interest may offer and sell the securitiesdescribed in this prospectus and any prospectus supplement from time to time, together or separately, to or through one or moreunderwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers oragents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discountarrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectussupplement. See the sections of this prospectus entitled “About this Prospectus” and “Plan of Distribution” for more information. Nosecurities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and termsof the offering of such securities. Our Class A Common Stock is listed on the Nasdaq Capital Market under the symbol “HIT”. On June 23, 2026, the lastreported sale price of our Class A Common Stock on the Nasdaq Capital Market was $0.99 per share. INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE “RISK FACTORS” ON PAGE 4 OF THISPROSPECTUS AND ANY SIMILAR SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENTCONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved ofthese securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminaloffense. The date of this prospectus is June 24, 2026. TABLE OF CONTENTS ABOUT THIS PROSPECTUS1WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE2THE COMPANY3RISK FACTORS4USE OF PROCEEDS5DESCRIPTION OF CAPITAL STOCK6SELLING STOCKHOLDERS12PLAN OF DISTRIBUTION14LEGAL MATTERS16EXPERTS16 ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-3 that we filed with the U.S. Securities and ExchangeCommission (the “SEC”) using a “shelf” registration process. By using a shelf registration statement, the selling stockholders maysell securities from time to time and in one or more offerings up to 5,600,000 shares of Class A Common Stock as described in thisprospectus. Each time that the selling stockholders offer and sell securities, the selling stockholders will provide a prospectussupplement to this prospectus that contains specific information about the securities being offered and sold and the specific termsof that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain materialinformation relating to these offerings. The prospectus supplement or free writing prospectus may also add, update or changeinformation contained in this prospectus with respect to that offering. If there is any inconsistency between the information in thisprospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement orfree writing prospectus, as applicable. Before purchasing any securities, you should carefully read both this prospectus and theapplicable prospectus supplement (and any applicable free writing prospectuses), together with the additional informationdescribed under the heading “Where You Can Find More Information; Incorporation by Reference.” Neither we, nor the selling stockholders, have authorized anyone to provide you with any information or to make anyrepresentations other than those contained in this prospectus, any applicable prospectus supplement or any free writingprospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide noassurance as to the reliability of, any other information that others may give you. We will not make an offer to sell these securitiesin any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus andthe applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the informationappearing in any applicable free writing prospectus is accurate only as of the date of that free writing prospectus, and that anyinformation incorporated by reference is accurate only as of the date of the d